Pharmacoeconomic analysis of botulinum toxin in complex therapy for cerebral palsy
We have performed the fi rst-ever pharmacoeconomic analysis in a Russian context of botulin toxin drugs as part of combined therapy for juvenile cerebral palsy (JCP) compared to standard clinical practice. Along with health economic modelling, an analysis of “routine clinical practice” was conducted...
Main Authors: | A. S. Kolbin, I. A. Vilum, M. A. Proskurin, Yu. E. Balykina |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Izdatelstvo OKI
2018-06-01
|
Series: | Качественная клиническая практика |
Subjects: | |
Online Access: | https://www.clinvest.ru/jour/article/view/193 |
Similar Items
-
Pharmacoeconomic analysis of the use of botulinum toxin in the treatment of poststroke spasticity
by: A. S. Kolbin, et al.
Published: (2018-05-01) -
Use of botulinum toxin in children with cerebral palsy
by: Monika Stecko, et al.
Published: (2019-07-01) -
The efficiency of high dose botulinum toxin type-A in the treatment of cerebral palsy
by: Alper İbrahim Dai
Published: (2014-03-01) -
Reducing severe spasticity in cerebral palsy following meningoencephalitis by botulinum toxin
by: Prastiya I. Gunawan, et al.
Published: (2017-05-01) -
USE OF BOTULINUM TOXIN TYPE A IN THE TREATMENT OF SPASTICITY IN CHILDREN WITH CEREBRAL PALSY
by: Ljiljana Lazić, et al.
Published: (2011-06-01)